Logistics & Transportation

Videos

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Joe Lipari, director of product management, Systech, describes the latest state of DSCSA implementation guidelines.

Navigating DSCSA Delays

Articles

A total of 140 companies are being placed on the Entity List, in an effort to limit China’s effectiveness in the sector. 

United States Protests China’s Semiconductor Chip Industry, Announces Export Restrictions

The transaction reaffirms the CDMO’s interest in growth on a global scale. 

Adragos Pharma Acquires Baccinex, Growing Sterile Manufacturing Services  

Podcasts

Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.

Nov. 27 is Here: What Does That Mean for DSCSA?

In the second part of this roundtable discussion, key opinion leaders discuss the potential technological challenges surrounding RFID, and the likelihood of not only utilizing this tech at the item level but for product security purposes as well. 

Peer Exchange: RFID Technological Obstacles (Episode 2)

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Gaurav Gupta, managing director and head of R&D at Kotter, outlines the steps that pharma leaders should keep in mind to when combatting supply chain issues.

Properly Preparing for Supply Chain Disruptions 

The collaboration is centered on standardization and the promotion of safety data sharing when it comes to ground handling. 

IATA and ASA Boost Partnership

In the first part of this roundtable discussion, a panel of subject matter experts introduce themselves, while discussing why the pharma supply chain sees value in this technology and why its use has fluctuated over the past decade.

Peer Exchange: An Overview of RFID Within the Pharmaceutical Industry (Episode 1)

The 50,000 square-foot plant is expected to augment the compounding and fulfillment experience for telehealth companies. 

Strive Compounding Pharmacy Eyes Expansion, Purchases St. Louis Facility

The 13,400 square-foot Belgium site will expand the company’s branded standardized bioprocessing, cryopreservation, and distribution solution for the cell therapy market, with a focus on leukapheresis starting materials.